398 related articles for article (PubMed ID: 32769032)
1. Action of metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study.
Adeshara KA; Bangar NS; Doshi PR; Diwan A; Tupe RS
Diabetes Metab Syndr; 2020; 14(5):1449-1458. PubMed ID: 32769032
[TBL] [Abstract][Full Text] [Related]
2. Plasma glycation adducts and various RAGE isoforms are intricately associated with oxidative stress and inflammatory markers in type 2 diabetes patients with vascular complications.
Adeshara KA; Bangar N; Diwan AG; Tupe RS
Diabetes Metab Syndr; 2022 Mar; 16(3):102441. PubMed ID: 35247657
[TBL] [Abstract][Full Text] [Related]
3. Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: a randomized clinical trial.
Esteghamati A; Eskandari D; Mirmiranpour H; Noshad S; Mousavizadeh M; Hedayati M; Nakhjavani M
Clin Nutr; 2013 Apr; 32(2):179-85. PubMed ID: 22963881
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of pioglitazone and metformin on oxidative stress markers in newly diagnosed type 2 diabetes patients: a randomized clinical trial.
Mirmiranpour H; Mousavizadeh M; Noshad S; Ghavami M; Ebadi M; Ghasemiesfe M; Nakhjavani M; Esteghamati A
J Diabetes Complications; 2013; 27(5):501-7. PubMed ID: 23891275
[TBL] [Abstract][Full Text] [Related]
5. Pioglitazone inhibits advanced glycation induced protein modifications and down-regulates expression of RAGE and NF-κB in renal cells.
Adeshara KA; Agrawal SB; Gaikwad SM; Tupe RS
Int J Biol Macromol; 2018 Nov; 119():1154-1163. PubMed ID: 30096396
[TBL] [Abstract][Full Text] [Related]
6. Sitagliptin attenuates arterial calcification by downregulating oxidative stress-induced receptor for advanced glycation end products in LDLR knockout mice.
Lin CP; Huang PH; Chen CY; Wu MY; Chen JS; Chen JW; Lin SJ
Sci Rep; 2021 Sep; 11(1):17851. PubMed ID: 34497344
[TBL] [Abstract][Full Text] [Related]
7. Albumin Oxidation and Albumin Glycation Discordance During Type 2 Diabetes Therapy: Biological and Clinical Implications.
Vaishnav MS; Kumari N; Srikanta S; Simha V; Krishnaswamy PR; Balaram P; Bhat N
Metab Syndr Relat Disord; 2024 Jun; 22(5):372-384. PubMed ID: 38696648
[No Abstract] [Full Text] [Related]
8. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives.
Khalid M; Petroianu G; Adem A
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454131
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic role of Syzygium cumini (L.) Skeels in glycation induced diabetic nephropathy via RAGE-NF-κB pathway and extracellular proteins modifications: A molecular approach.
Apte MM; Khattar E; Tupe RS
J Ethnopharmacol; 2024 Mar; 322():117573. PubMed ID: 38110133
[TBL] [Abstract][Full Text] [Related]
10. Divergent Changes in Plasma AGEs and sRAGE Isoforms Following an Overnight Fast in T1DM.
Miranda ER; Fuller KNZ; Perkins RK; Beisswenger PJ; Farabi SS; Quinn L; Haus JM
Nutrients; 2019 Feb; 11(2):. PubMed ID: 30781793
[TBL] [Abstract][Full Text] [Related]
11. Effect of metformin combined with lifestyle modification versus lifestyle modification alone on proinflammatory-oxidative status in drug-naïve pre-diabetic and diabetic patients: A randomized controlled study.
Bulatova N; Kasabri V; Qotineh A; Al-Athami T; Yousef AM; AbuRuz S; Momani M; Zayed A
Diabetes Metab Syndr; 2018 May; 12(3):257-267. PubMed ID: 29221717
[TBL] [Abstract][Full Text] [Related]
12. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.
Basta G; Sironi AM; Lazzerini G; Del Turco S; Buzzigoli E; Casolaro A; Natali A; Ferrannini E; Gastaldelli A
J Clin Endocrinol Metab; 2006 Nov; 91(11):4628-34. PubMed ID: 16926247
[TBL] [Abstract][Full Text] [Related]
13. The Effect of 600 mg Alpha-lipoic Acid Supplementation on Oxidative Stress, Inflammation, and RAGE in Older Adults with Type 2 Diabetes Mellitus.
Mendoza-Núñez VM; García-Martínez BI; Rosado-Pérez J; Santiago-Osorio E; Pedraza-Chaverri J; Hernández-Abad VJ
Oxid Med Cell Longev; 2019; 2019():3276958. PubMed ID: 31285784
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.
Tam XH; Shiu SW; Leng L; Bucala R; Betteridge DJ; Tan KC
Clin Sci (Lond); 2011 Jan; 120(2):81-9. PubMed ID: 20726839
[TBL] [Abstract][Full Text] [Related]
15. Experimental Hyperglycemia Alters Circulating Concentrations and Renal Clearance of Oxidative and Advanced Glycation End Products in Healthy Obese Humans.
Perkins RK; Miranda ER; Karstoft K; Beisswenger PJ; Solomon TPJ; Haus JM
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30823632
[TBL] [Abstract][Full Text] [Related]
16. DNA Aptamer Raised against Advanced Glycation End Products Improves Sperm Concentration, Motility, and Viability by Suppressing Receptors for Advanced Glycation End Product-Induced Oxidative Stress and Inflammation in the Testes of Diabetic Mice.
Mori Y; Terasaki M; Osaka N; Fujikawa T; Yashima H; Saito T; Kataoka Y; Ohara M; Higashimoto Y; Matsui T; Yamagishi SI
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892134
[TBL] [Abstract][Full Text] [Related]
17. The Effects of Vitamin D Supplementation on Metabolic and Oxidative Stress Markers in Patients With Type 2 Diabetes: A 6-Month Follow Up Randomized Controlled Study.
Cojic M; Kocic R; Klisic A; Kocic G
Front Endocrinol (Lausanne); 2021; 12():610893. PubMed ID: 34489860
[TBL] [Abstract][Full Text] [Related]
18. The Role of Oxidative Stress, Inflammation, and Advanced Glycation End Product in Skin Manifestations of Diabetes Mellitus.
Legiawati L
Curr Diabetes Rev; 2022; 18(3):e200921196637. PubMed ID: 34544349
[TBL] [Abstract][Full Text] [Related]
19. Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial.
Kellow NJ; Coughlan MT; Savige GS; Reid CM
BMC Endocr Disord; 2014 Jul; 14():55. PubMed ID: 25011647
[TBL] [Abstract][Full Text] [Related]
20. Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.
Yubero-Serrano EM; Woodward M; Poretsky L; Vlassara H; Striker GE;
Clin J Am Soc Nephrol; 2015 May; 10(5):759-66. PubMed ID: 25710801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
